Products
Online Inquiry
Indeglitazar
Cat. No.:
0225LY-0841
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Indeglitazar is an orally active pan-agonist that targets all three peroxisome proliferator-activated receptor subtypes, specifically alpha, delta, and gamma.
Synonym:
PPM 204; 835619-41-5; PPM-204; 3-(5-Methoxy-1-((4-methoxyphenyl)sulfonyl)-1H-indol-3-yl)propanoic acid; 3-(5-methoxy-1-(4-methoxybenzenesulfonyl)-1H-indol-3-yl)propanoic acid; 3-[5-methoxy-1-(4-methoxybenzenesulfonyl)-1H-indol-3-yl]propanoic acid; 1H-Indole-3-propanoic acid, 5-methoxy-1-((4-methoxyphenyl)sulfonyl)-; 3-[1-(4-Methoxy benzenesulfonyl)-5-methoxy-1H-indol-3-yl]-propionic acid; 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid; 3-[5-Methoxy-1-(4-methoxybenzene-1-sulfonyl)-1H-indol-3-yl]propanoato
CAS No.:
835619-41-5
Compound CID:
11395145
Formula:
C19H19NO6S
Formula Weight:
389.42
Specification
Relative Density:
1.34 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Indeglitazar can be used in metabolic research to study the pan-PPAR agonism involving the alpha, gamma, and delta isoforms.
Library Information
Target:
PPAR
Receptor:
PPARα; PPARγ; PPARδ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-11
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
90 mg/mL; 231.11 mM
